EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Population‐Based Multi‐Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease

Tianxing Wu iD, Jialiang Luo, Haoyuan Qiu, Weijie Shao, Yueyang Lu, Meixuan Luo, Zhaofeng Lin, Yan Zhang, Libo Zhang, Hong Wang, Jia Zhou, Guangfeng Ruan und 2 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202514130 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Advanced Science, 2026. Verfasst von Tianxing Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510260, China. Hauptthemen laut MEDLINE: Psoriasis, Biomarkers. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Guangzhou, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Medical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriatic disease (PsD) is a chronic inflammatory disease, with significant challenges in early risk stratification and drug development. Integration of proteomic and genomic data provides an unprecedented opportunity to identify predictive biomarkers and therapeutic targets for PsD. Here, through systemic genetic analyses, expression validation, and prospective cohort study, CDSN and PRSS8 were identified as candidate biomarkers and potential therapeutic targets for PsD. Individuals with higher levels of CDSN and PRSS8 were nearly three times more likely to develop PsD compared to the general population. It develops prediction models in adults without PsD at baseline from the UK Biobank. Combining CDSN and PRSS8 with demographics produced desirable predictions for PsD (area under the curve (AUC) = 0.80) and exhibited high specificity. Moreover, PRSS8 and CDSN were both predominantly localized in keratinocytes, and in vivo gene silencing of these proteins significantly reduced PsD‐like skin lesions and systemic inflammatory markers. The findings strongly suggested that CDSN and PRSS8 are promising biomarkers for PsD onset and progression, providing a 12‐year risk assessment window and potential as novel therapeutic targets. These results had important implications for screening high‐risk populations and facilitating early intervention for PsD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisBiomarkersHumansMaleFemaleAdultMiddle AgedCohort StudiesProteomicsProspective StudiesMultiomics

Stichwörter der Autor:innen

biomarkerpredictive modelpsoriatic diseasesi‐RNAtherapy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510260, China.
  • Institute of Molecular Immunology, Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, 510515,…
  • Department of Dermatology, Guangdong Medical Products Administration Key Laboratory for Research and Evaluation of Drugs for Inflammatory Diseases, the Fifth Affiliated Hospital, Southern Medical University, Guangzhou,…
  • Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China.
  • The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
  • Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510515, China.

ORCID-Profile: Tianxing Wu, Daming Zuo

Förderung

  • Science and Technology Program of Guangzhou
  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Medical Research Fund
  • National Natural Science Foundation of China
  • Guangdong S&T programme
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Wu, T., Luo, J., Qiu, H., Shao, W., Lu, Y., Luo, M., Lin, Z., Zhang, Y., Zhang, L., Wang, H., Zhou, J., Ruan, G., Cao, P., & Zuo, D. (2026). Population‐Based Multi‐Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease. Advanced Science. https://doi.org/10.1002/advs.202514130

Vancouver

Wu T, Luo J, Qiu H, Shao W, Lu Y, Luo M, et al. Population‐Based Multi‐Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease. Advanced Science. 2026. doi:10.1002/advs.202514130

BibTeX
@article{Wu2026,
  author = {Wu, Tianxing and Luo, Jialiang and Qiu, Haoyuan and Shao, Weijie and Lu, Yueyang and Luo, Meixuan and Lin, Zhaofeng and Zhang, Yan and Zhang, Libo and Wang, Hong and Zhou, Jia and Ruan, Guangfeng and Cao, Peihua and Zuo, Daming},
  title = {Population‐Based Multi‐Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202514130}
}
Kostenlos starten →